Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
NCT ID: NCT01844622
Last Updated: 2017-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2007-12-31
2015-02-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Domperidone for Refractory Gastrointestinal Disorders
NCT00777439
Treatment Use of Domperidone for Gastroparesis
NCT02227927
Use of Domperidone for Treatment of Upper Gastrointestinal Disorders
NCT03128398
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Domperidone
Domperidone will be given at 10 mg before each meal and at bedtime. At completion of the study, patients will receive standard medical therapy
Domperidone
Domperidone dosage may be increased depending on how well the patient responds. However before increasing the dosage, patients will have follow-up EKG to evaluate any possible side effects including irregular heartbeats.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Domperidone
Domperidone dosage may be increased depending on how well the patient responds. However before increasing the dosage, patients will have follow-up EKG to evaluate any possible side effects including irregular heartbeats.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Heartburn
* Nausea
* Vomiting
* Severe dyspepsia
* Severe chronic constipation
Exclusion Criteria
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mt. Sinai Medical Center, Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie S. Barkin, M.D.
Professor of Medicine, U of Miami and Chief, Div of GI, Mt. Sinai Med. Ctr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamie S. Barkin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mt. Sinai Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Gastroenterology, Mt. Sinai Medical Center
Miami Beach, Florida, United States
Mt. Sinai Medical Center, Division of Gastroenterology
Miami Beach, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-39-H-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.